• Profile
Close

Testosterone replacement therapy is associated with an increased risk of urolithiasis

World Journal of Urology Nov 28, 2019

McClintock TR, Valovska MTI, Kwon NK, et al. - In this population-based matched cohort study using data sourced from the Military Health System Data Repository of men aged 40–64 years with no former history of urolithiasis who received continuous testosterone replacement therapy (TRT, n = 26,586) for a diagnosis of hypogonadism between 2006 and 2014, experts ascertained whether TRT in men with hypogonadism was related to a progressed risk of urolithiasis. Among those on TRT, in comparison with those who did not undergo this hormonal therapy, an improvement in the 2-year absolute risk of stone events was noted.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay